Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Mar 7, 2013 8:30 am EST

RXi Pharmaceuticals Announces $16.4 Million Placement of Common Stock

Mar 7, 2013 8:30 am EST

RXi Pharmaceuticals and OPKO Health Announce Strategic Pooling of RNAi Assets

Mar 4, 2013 4:27 pm EST

OPKO Health Completes Acquisition of Two Phase 3 Products

Mar 1, 2013 8:16 am EST

OPKO Point-of-Care Technology Demonstrated on Mobile Device with Cloud Connectivity to Diagnose and Track Disease in Africa

Feb 15, 2013 4:27 pm EST

OPKO Health Completes Acquisition of Brazilian Pharmaceutical Company

Feb 8, 2013 12:24 pm EST

Clarification Regarding Exercise and Sale of Common Stock Options by OPKO Health Company Officer

Jan 31, 2013 8:00 am EST

OPKO Closes Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033

Jan 25, 2013 8:02 am EST

OPKO Prices Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033

Jan 23, 2013 4:04 pm EST

OPKO Announces Proposed Private Offering of $150 Million Convertible Senior Notes Due 2033

Jan 14, 2013 8:30 am EST

OPKO Health Expands Collaboration with Bristol-Myers Squibb